Ergoteles’s Y-mAbs Therapeutics YMAB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-191,869
| Closed | -$936K | – | 1814 |
|
2022
Q4 | $936K | Buy |
+191,869
| New | +$936K | 0.03% | 479 |
|
2022
Q3 | – | Sell |
-28,697
| Closed | -$434K | – | 2050 |
|
2022
Q2 | $434K | Buy |
28,697
+5,634
| +24% | +$85.2K | 0.01% | 903 |
|
2022
Q1 | $274K | Buy |
23,063
+4,497
| +24% | +$53.4K | 0.01% | 875 |
|
2021
Q4 | $301K | Buy |
+18,566
| New | +$301K | 0.01% | 850 |
|
2020
Q4 | – | Sell |
-5,224
| Closed | -$201K | – | 946 |
|
2020
Q3 | $201K | Buy |
+5,224
| New | +$201K | 0.03% | 483 |
|